E’ previsto l’intervento della Dott.ssa Enrica Tornielli (Vicecoordinatore IBG - Italian Biosimilars Group) alla seguente tavola rotonda:
12.00 - 13.00 - Round table “Which priorities for the post-marketing monitoring of biological drugs in clinical practice?”


